Study to Evaluate SID 530 Compared to Taxotere
NCT00931008
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG:
SID530, Taxotere
Sponsor
SK Chemicals Co., Ltd.